Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
| Form | Size | Price | $/mg | Stock | Updated |
|---|---|---|---|---|---|
| vial | 5mg | $35.00 | $7.00/mg | In stock | Jul 7 |
| vial | 10mg | $42.00 | $4.20/mg | In stock | Jul 7 |
| nasal | 30mg | $99.00 | $3.30/mg | In stock | Jul 7 |
Single-vial list prices — bulk or bundle orders may be lower. Verify at vendor before purchase.
The FDA PCAC advisory committee meets July 23–24, 2026 to review nominations and make recommendations on compounding eligibility — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. Ipamorelin is on the proposed list. If the FDA subsequently issues a final rule, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Disclosed Labs does not provide medical or legal advice.
Does Ion Peptide sell Ipamorelin?
Yes — Ion Peptide currently lists Ipamorelin in 3 variants starting at $99.00 ($3.30/mg).
Is Ion Peptide's Ipamorelin third-party tested?
Yes — Disclosed Labs has indexed 12 Certificates of Analysis for Ion Peptide's Ipamorelin, with the most recent showing 99.9% purity. Ion Peptide holds an overall trust grade of A (92/100) across all 560 COAs on file.
What is Ion Peptide's trust grade for Ipamorelin?
Ion Peptide has an overall Disclosed Labs trust grade of A (92/100), computed from 560 COAs across all peptides. The most recent Ipamorelin COA was issued by ILS Labs.
Where is the cheapest Ipamorelin?
As of the latest data, Peptide Supply Co. offers Ipamorelin at $2.70/mg — compare with Ion Peptide's listing at $3.30/mg. See the full Ipamorelin price comparison.
Is Ipamorelin legal to buy?
Ipamorelin is among the peptides under FDA review for the Category 1 (503A) bulk-substances list — removed from Category 2 in April 2026 but not yet on a finalized Category 1 list. The FDA PCAC committee meets July 23–24, 2026 to make recommendations on which peptides may be compounded, and under what conditions — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. If a final rule is ultimately issued, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Current sales are for research purposes only. Disclosed Labs does not provide medical or legal advice.
| Endotoxin, Sterility, Heavy metals |
| Unverified1 flag |
| View |
| — | Feb 2026 | 99.6% | Analytical Formulations, Inc. | Heavy metals | Unverified | View |
| IPA10-02022026 | Feb 2026 | 99.6% | Analytical Formulations, Inc. | Heavy metals | Unverified | View |
| IPA5-01142026 | Jan 2026 | 100.0% | Freedom Diagnostics | — | Confirmed | View |
| IPA10-010226 | Jan 2026 | 99.8% | Bioviridian | — | Confirmed | View |
| IPA10-120425 | Dec 2025 | 99.9% | Freedom Diagnostics | — | Confirmed | View |
| IP10-1025 | Dec 2025 | 99.8% | Freedom Diagnostics | — | Confirmed | View |
| IPS-1125 | Nov 2025 | 99.6% | Freedom Diagnostics | — | Unverified | View |
| CJL-0926 | Oct 2025 | 99.7% | Freedom Diagnostics | — | Confirmed | View |
| — | Sep 2025 | 99.7% | Freedom Diagnostics | — | Unverified | View |
| IPA10-04072026 | — | 100.0% | Kovera Labs | Endotoxin, Sterility, Heavy metals | Confirmed1 flag | View |